Patents by Inventor Gert Strandlund

Gert Strandlund has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oxabispidine compounds for the treatment of cardiac arrhythmias
    Patent number: 7928225
    Abstract: There is provided compounds of formula I, wherein R1, R2, R3, R41 to R46, X, Y and Z have meanings given in the description, which compounds are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Grant
    Filed: June 12, 2006
    Date of Patent: April 19, 2011
    Assignee: AstraZeneca AB
    Inventors: Annika Björe, David Cladingboel, Gareth Ensor, Adam Herring, Johan Kajanus, Robert Lundqvist, Christina Olsson, Carl-Gustav Sigfridsson, Gert Strandlund
  • Isoindoline Derivatives For The Treatment Of Arrhythmias
    Publication number: 20100298392
    Abstract: There is provided compounds of formula I, wherein R1 to R7 have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Application
    Filed: July 12, 2007
    Publication date: November 25, 2010
    Applicant: ASTRAZENECA AB
    Inventors: Annika Bjore, Jonas Bostrom, Ojvind Davidsson, Hans Emtenas, Ulrik Gran, Tommy Iliefski, Johan Kajanus, Roine Olsson, Lars Sandberg, Gert Strandlund, Johan Sundell, Zhong-Qing Yuan
  • Oxabispidine compounds useful in the treatment of cardiac arrhythmias
    Patent number: 7772229
    Abstract: There is provided compounds of formula I, wherein R1, R2, R3, R4, R41 to R46, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Grant
    Filed: March 22, 2006
    Date of Patent: August 10, 2010
    Assignee: AstraZeneca AB
    Inventors: Annika Björe, Magnus Björsne, Kurt-Jürgen Hoffmann, Fritiof Pontėn, Gert Strandlund, Peder Svensson, Michael Wilsterman
  • New oxabispidine compunds useful in the treatment of cardiac arrhythmias
    Publication number: 20090326221
    Abstract: There is provided compounds of formula I, wherein R1, R2, R3, R4, R41 to R46, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Application
    Filed: September 1, 2009
    Publication date: December 31, 2009
    Applicant: AstraZeneca AB,
    Inventors: Annika Bjore, Magnus Bjorsne, David Cladingboel, Kurt-Jurgen Hoffman, John Pavey, Fritiof Ponten, Gert Strandlund, Peder Svensson, Colin Thomson, Michael Wilsterman
  • Novel Oxabispidine Compounds And Their Use In The Treatment Of Cardiac Arrhythmias
    Publication number: 20090099162
    Abstract: There is provided compounds of formula I, wherein R1, R2, R4, R41 to R46, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Application
    Filed: February 11, 2008
    Publication date: April 16, 2009
    Applicant: AstraZeneca AB
    Inventors: Annika Bjore, Ulrik Gran, Gert Strandlund
  • New Oxabispidine Compounds For The Treatment Of Cardiac Arrhythmias
    Publication number: 20090054422
    Abstract: There is provided compounds of formula I, wherein R1, R2, R3, R41 to R46, X, Y and Z have meanings given in the description, which compounds are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Application
    Filed: June 12, 2006
    Publication date: February 26, 2009
    Applicant: ASTRAZENECA AB
    Inventors: Annika Bjore, David Cladingboel, Gareth Ensor, Adam Herring, Johan Kajanus, Robert Lundqvist, Christina Olsson, Carl-Gustav Sigfridsson, Gert Strandlund
  • Novel Oxabispidine Compounds And Their Use In The Treatment Of Cardiac Arrhythmias
    Publication number: 20080319198
    Abstract: There is provided compounds of formula I, wherein R1, R2, R4, R41 to R46, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Application
    Filed: February 12, 2008
    Publication date: December 25, 2008
    Applicant: AstraZeneca AB
    Inventors: Annika Bjore, Ulrik Gran, Gert Strandlund
  • Novel Oxabispidine Compounds And Their Use In The Treatment Of Cardiac Arrhythmias
    Publication number: 20080249086
    Abstract: There is provided compounds of formula I, wherein R1, R2, R4, R41 to R46, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Application
    Filed: February 11, 2008
    Publication date: October 9, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Annika Bjore, Ulrik Gran, Gert Strandlund
  • Novel Oxabispidine Compounds And Their Use In The Treatment Of Cardiac Arrhythmias
    Publication number: 20080207899
    Abstract: There is provided compounds of formula I, wherein R1, R2, R4, R41 to R46, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Application
    Filed: February 12, 2008
    Publication date: August 28, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Annika Bjore, Ulrik Gran, Gert Strandlund
  • Novel Oxabispidine Compounds And Their Use In The Treatment Of Cardiac Arrhythmias
    Publication number: 20080146812
    Abstract: There is provided compounds of formula I, wherein R1, R2, R4, R41 to R46, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Application
    Filed: February 12, 2008
    Publication date: June 19, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Annika Bjore, Ulrik Gran, Gert Strandlund
  • Oxabispidine compounds and their use in the treatment of cardiac arrhythmias
    Patent number: 7354917
    Abstract: There is provided compounds of formula I, wherein R1, R2, R4, R41 to R46, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular a trial and ventricular arrhythmias.
    Type: Grant
    Filed: June 13, 2005
    Date of Patent: April 8, 2008
    Assignee: AstraZeneca AB
    Inventors: Annika Bjore, Ulrik Gran, Gert Strandlund
  • Oxabispidine compounds useful in the treatment of cardiac arrhythmias
    Patent number: 7351821
    Abstract: There is provided compounds of formula I, wherein R1, R2, R3, R4, R41 to R46, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Grant
    Filed: December 18, 2006
    Date of Patent: April 1, 2008
    Assignee: AstraZeneca AB
    Inventors: Annika Björe, Magnus Björsne, David Cladingboel, Kurt-Jürgen Hoffmann, John Pavey, Fritiof Pontén, Gert Strandlund, Peder Svensson, Colin Thomson, Michael Wilsterman
  • NEW COMPOUNDS I/418
    Publication number: 20080015237
    Abstract: There is provided compounds of formula I, wherein R1 to R7 have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Application
    Filed: July 11, 2007
    Publication date: January 17, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Annika Bjore, Jonas Bostrom, Ojvind Davidsson, Hans Emtenas, Ulrik Gran, Tommy Iliefski, Johan Kajanus, Roine Olsson, Gert Strandlund, Johan Sundell, Zhong-Qing Yuan, Lars Sandberg
  • Novel Oxabispidine Compounds and Their Use in the Treatment of Cardiac Arrhythmias
    Publication number: 20070259864
    Abstract: There is provided compounds of formula I, wherein R1, R2, R4, R41 to R46, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Application
    Filed: June 13, 2005
    Publication date: November 8, 2007
    Applicant: ASTRAZENECA AB
    Inventors: Annika Bjore, Ulrik Gran, Gert Strandlund
  • Oxabispidine compounds useful in the treatment of cardiac arrhythmias
    Publication number: 20070117799
    Abstract: There is provided compounds of formula I, wherein R1, R2, R3, R4, R41 to R46, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Application
    Filed: December 18, 2006
    Publication date: May 24, 2007
    Inventors: Annika Bjore, Magnus Bjorsne, David Cladingboel, Kurt-Jurgen Hoffmann, John Pavey, Fritiof Ponten, Gert Strandlund, Peder Svensson, Colin Thomson, Michael Wilsterman
  • Chemical compound and assay
    Publication number: 20070048215
    Abstract: The present invention relates to a labelled ligand compound that is useful in a method of identifying, testing and/or screening of compounds modulating ion channels, in particular myocardial I?Kr# 191 channels such as those encoded by ERG, including hERG. The ligand compound is therefore of use to evaluate the affinity of preclinical compounds at the ERG potassium channel. The or salts, hydrates or solvates thereof and comprising at least one radiolabel: Formula (I).
    Type: Application
    Filed: October 18, 2004
    Publication date: March 1, 2007
    Inventors: Brian Springthorpe, Gert Strandlund
  • 3,7-diazabicyclo[3.3.0]octanes and their use in the treatment of cardiac arrhythmias
    Patent number: 7144914
    Abstract: There is provided compounds of formula (I) wherein R1 to R4, Ra to Rf, A and B have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Grant
    Filed: January 29, 2002
    Date of Patent: December 5, 2006
    Assignee: Astrazeneca AB
    Inventors: Magnus Björsne, Fritiof Pontén, Gert Strandlund, Peder Svensson, Michael Wilstermann
  • New oxabispidine compounds useful in the treatment of cardiac arrhythmias
    Publication number: 20060166979
    Abstract: There is provided compounds of formula I, wherein R1, R2, R3, R4, R41 to R46, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Application
    Filed: March 22, 2006
    Publication date: July 27, 2006
    Applicant: AstraZeneca AB
    Inventors: Annika Bjore, Magnus Bjorsne, Kurt-Jurgen Hoffmann, Fritiof Ponten, Gert Strandlund, Peder Svensson, Michael Wilsterman
  • New oxabispidine compounds useful in the treatment of cardiac arrhythmias
    Publication number: 20060166980
    Abstract: There is provided compounds of formula I, wherein R1, R2, R3, R4, R41 to R46, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Application
    Filed: March 22, 2006
    Publication date: July 27, 2006
    Applicant: AstraZeneca AB
    Inventors: Annika Bjore, Magnus Bjorsne, David Cladingboel, Kurt-Jurgen Hoffmann, John Pavey, Fritiof Ponten, Gert Strandlund, Peder Svensson, Colin Thomson, Michael Wilsterman
  • 3,8-Diazabicyclo[3.2.1]octanes and their use in the treatment of cardiac arrhythmias
    Patent number: 7012074
    Abstract: There is provided compounds of formula (I), wherein R1, R2 and Ra to Rb have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Grant
    Filed: October 18, 2001
    Date of Patent: March 14, 2006
    Assignee: AstraZeneca AB
    Inventors: Magnus Bjorsne, Kurt-Jürgen Hoffmann, Fritiof Pontén, Gert Strandlund, Peder Svensson, Michael Wilstermann